肺狭窄症治疗的进展
1Cardiology & Cardiac Surgery, Department of Clinical Sciences, Colorado State University, 200 West Lake Street, 1678 Campus Delivery, Fort Collins, CO 80523-1678, USA.
概括
肺狭窄症是狗中常见的一种先天性心脏缺陷,尤其是胸头型犬种. 跨肺支架植入为患有严重膜发育不良的狗提供了一个新的选择,这些狗对传统治疗没有反应.
科学领域:
- 兽医心脏病学 兽医心脏病学
- 比较病理学比较病理学
背景情况:
- 肺狭窄 (PVS) 是狗中最常见的先天性心脏缺陷.
- 增加的患病率与脑型犬种的受欢迎程度有关.
- 目前的治疗方法,如β阻塞和气球肺膜整形,缺乏可靠的证据,并且有局限性.
研究的目的:
- 审查新兴的治疗转肺支架植入犬肺狭窄的治疗方法.
- 讨论其在膜发育不良或气球膜整形失败的情况下的应用.
主要方法:
- 本综述综合了目前关于跨肺支架植入的知识和临床经验.
- 重点是涉及形门或气球后膜成形并发症的病例.
主要成果:
- 气球肺膜整形对于厚厚的,失塑的门不那么有效.
- 跨肺支架植入被提出为特定犬类PVS病例的可行替代方案.
- 该研究提供了对这种新型干预程序的当前经验的见解.
结论:
- 跨肺支架植入是犬肺狭窄症的有前途的治疗选择,特别是在耐火病例中.
- 需要进一步的研究和标准化的协议来优化结果.
- 这种方法扩大了复杂门异常的狗的治疗可能性.
关键词:
气球膜整形手术 气球膜整形手术狗类犬类动物 狗类犬类遗传性心脏病是一种先天性心脏病.狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗肺部狭窄症 肺部狭窄症支架植入植入植入的支架植入.更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Regurgitation III: Medical Management
19
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
19
Mitral Stenosis IV: Nursing Management
15
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
15
Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Mitral Stenosis I: Introduction
18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23


